Compounds > clopidogrel

clopidogrel and transforming growth factor beta

clopidogrel has been researched along with transforming growth factor beta in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Albertson, CM; Fink, LM; Hauer-Jensen, M; Herbert, JM; Wang, J; Zheng, H1
Daig, U; Eisenberg, R; Gaedeke, J; Krämer, S; Liefeldt, L; Neumayer, HH; Peters, H; Westenfeld, R1
Cui, W; Du, J; Jia, LX; Li, TT; Liu, O; Qi, GM; Qi, YF; Yang, M; Zhang, WM1
Hou, J; Jiang, Z; Liu, Q; Sun, M; Wang, S; Wang, W; Wang, Y; Yu, B; Zhang, H; Zhang, R; Zhao, Q1
Chen, J; Huang, XR; Lan, HY; Tang, PM; Tang, Y; Wei, B; Xu, A; Zhong, Y1

Other Studies

5 other study(ies) available for clopidogrel and transforming growth factor beta

ArticleYear
Short-term inhibition of ADP-induced platelet aggregation by clopidogrel ameliorates radiation-induced toxicity in rat small intestine.
    Thrombosis and haemostasis, 2002, Volume: 87, Issue:1

    Topics: Adenosine Diphosphate; Animals; Chemotaxis, Leukocyte; Clopidogrel; Collagen; Endothelium, Vascular; Enteritis; Extracellular Matrix; Fibrosis; Gastrointestinal Hemorrhage; Intestine, Small; Male; Muscle, Smooth; Neutrophils; Platelet Aggregation; Platelet Aggregation Inhibitors; Radiation Injuries, Experimental; Rats; Rats, Sprague-Dawley; RNA, Messenger; Ticlopidine; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1

2002
Platelet inhibition limits TGF-beta overexpression and matrix expansion after induction of anti-thy1 glomerulonephritis.
    Kidney international, 2004, Volume: 65, Issue:6

    Topics: Animals; Blood Platelets; Clopidogrel; Glomerulonephritis; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Thy-1 Antigens; Ticlopidine; Transforming Growth Factor beta; Transforming Growth Factor beta1

2004
Inhibition of platelet activation by clopidogrel prevents hypertension-induced cardiac inflammation and fibrosis.
    Cardiovascular drugs and therapy, 2013, Volume: 27, Issue:6

    Topics: Angiotensin II; Animals; Clopidogrel; Fibrosis; Hypertension; Interleukin-1beta; Male; Mice; Mice, Inbred C57BL; Myocarditis; Myocardium; Platelet Activation; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Ticlopidine; Transforming Growth Factor beta

2013
Effect of Clopidogrel vs Ticagrelor on Platelet Aggregation and Inflammation Markers After Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.
    The Canadian journal of cardiology, 2018, Volume: 34, Issue:12

    Topics: Biomarkers; C-Reactive Protein; Clopidogrel; Female; Humans; Interleukin-1beta; Interleukins; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Retrospective Studies; ST Elevation Myocardial Infarction; Ticagrelor; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha

2018
P2Y12 inhibitor clopidogrel inhibits renal fibrosis by blocking macrophage-to-myofibroblast transition.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2022, 09-07, Volume: 30, Issue:9

    Topics: Animals; Clopidogrel; Fibrosis; Kidney; Kidney Diseases; Macrophages; Mice; Mice, Inbred C57BL; Myofibroblasts; Renal Insufficiency, Chronic; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ureteral Obstruction

2022